24 янв 2018 г. - FDA and the Federal Trade Commission posted
joint warning letters to the marketers and
distributors of 12 opioid cessation products, for
illegally marketing unapproved products with
claims about their ability to help in the treatment
of opioid addiction and withdrawal.
